What is tesamorelin compounded with?

This site does not hold that information. Tesamorelin's US legal-status field is FDA approved for a specific indication, prescription only, as Egrifta. Approved Egrifta is a finished drug product with its own labeled composition. A compounded vial is a different article. Country fields do not list buffers, diluents, or carrier substances used by a compounding pharmacy. This FAQ does not invent a formula.

Educational use only. This database summarizes published research and is not medical advice. Where a dose appears it is a record of what a trial or clinic ran, or what people describe doing, with its source attached. Nothing here is a recommendation for personal use.

Part of more absences and national fields. Further harvested questions after the first names-and-absences set: more side effects the citations did not count, compounding formulas this catalogue does not hold, national legal-status fields for compounds that only have those four countries, trial windows rather than an onset clock, and named prescription combinations with no interaction table.